Cargando…
Pramipexole to Improve Cognition in Bipolar Disorder: A Randomized Controlled Trial
BACKGROUND: Adults with bipolar disorder (BD) often experience neurocognitive impairment that negatively impacts functioning and quality of life. Previous trials have found that dopamine agonist agents improve cognition in healthy volunteers and that adults with BD who have stable mood and mild cogn...
Autores principales: | Van Meter, Anna R., Perez-Rodriguez, M. Mercedes, Braga, Raphael J., Shanahan, Megan, Hanna, Lauren, Malhotra, Anil K., Burdick, Katherine E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238822/ https://www.ncbi.nlm.nih.gov/pubmed/33956703 http://dx.doi.org/10.1097/JCP.0000000000001407 |
Ejemplares similares
-
Modafinil’s effects on cognition and sleep quality in affectively-stable patients with bipolar disorder: a pilot study
por: Lipschitz, Jessica M., et al.
Publicado: (2023) -
Social cognition in patients with schizophrenia spectrum and bipolar disorders with and without psychotic features()
por: Nitzburg, George C., et al.
Publicado: (2015) -
The impact of lifetime interpersonal and intentional trauma on cognition and vulnerability to psychosis in bipolar disorder
por: Lebovitz, Julia G., et al.
Publicado: (2021) -
Pramipexole in the Treatment of Refractory Depression in a Patient with Rapid Cycling Bipolar Disorder
por: Hegde, Aditya, et al.
Publicado: (2015) -
Cognitive subgroups and their longitudinal trajectories in bipolar disorder
por: Ehrlich, Tobin J., et al.
Publicado: (2022)